Ensysce Biosciences To Host Symposium On Safer Analgesics At IASP 2024 World Congress; CEO Dr. Lynn Kirkpatrick To Introduce Event Featuring Pain Experts Dr. Lars Arendt-Nielsen And Dr. William Schmidt
Portfolio Pulse from Benzinga Newsdesk
Ensysce Biosciences will host a symposium on safer analgesics at the IASP 2024 World Congress. The event will be introduced by CEO Dr. Lynn Kirkpatrick and feature pain experts Dr. Lars Arendt-Nielsen and Dr. William Schmidt.
July 23, 2024 | 12:10 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Ensysce Biosciences is set to host a symposium on safer analgesics at the IASP 2024 World Congress, which could enhance its reputation and visibility in the healthcare sector.
Hosting a symposium at a major congress can increase Ensysce Biosciences' visibility and credibility in the healthcare sector, potentially attracting more interest from investors and partners.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100